Individuals with asthma and chronic obstructive pulmonary disease (COPD) were more vulnerable than healthy controls to ...

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung ...

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

Acute lung injury; CINC: Cytokine-induced neutrophil chemoattractant; CXCR: CXC chemokine receptor; ENA: Epithelial cell-derived neutrophil-activating peptide; GRO-α: Growth-related protein-α.

Researchers are tackling neutrophilic asthma, successfully developing one of the first mouse models of the condition.

Airway epithelial cells act as a physical barrier against environmental toxins and injury, and modulate inflammation and the immune response. As such, maintenance of their integrity is critical.

Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC)1 and OXB,1 today announce the start of LENTICLAIRTM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, gene ...

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...